Genomind – Pharmacogenetic Considerations for Treatment of the Geriatric Population

Join Genomind’s Vice President of Medical Affairs, Dr. Daniel Dowd, for a clinical presentation. Dr. Dowd discusses pharmacogenetic considerations that can be applied in the treatment of geriatric and comorbid patients. He also demonstrates how GenMed✓ Pro, Genomind’s precision gene-drug interaction software, can be utilized in the assessment of treatment options for this population.